Literature DB >> 1540495

Increases in plasma beta-endorphin concentrations during exercise do not contribute to increases in heart rate following autonomic blockade in man.

A Shen1, J Chin, M Fullerton, G Jennings, A Dart.   

Abstract

1. Intrinsic heart rate (IHR: heart rate following autonomic blockade with atropine and propranolol) increases with exercise. The opioid antagonist naloxone has been shown to decrease IHR at rest, raising the possibility that increases in IHR with exercise are beta-endorphin related, since beta-endorphin concentrations have also been shown to rise during exercise. 2. We examined the effects of naloxone (10 mg) on IHR and plasma beta-endorphin levels during aerobic exercise in eight healthy, male subjects in a single blind, crossover study. 3. IHR increased with 25 min bicycling from 97.1 +/- 1.4 to 129.7 +/- 1.2 beats min-1 (mean +/- s.e. mean). This rise was not affected by administration of naloxone. 4. Plasma beta-endorphin concentration rose from 31.1 +/- 3.8 to 94.9 +/- 23.9 pg ml-1 after 25 min exercise. This exercise-induced rise in beta-endorphin concentration was further increased (P less than 0.05) in the presence of naloxone. 5. Our results confirm a rise in IHR and beta-endorphin concentrations with acute exercise but indicate that the changes in IHR are not endorphin-related.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540495      PMCID: PMC1381204          DOI: 10.1111/j.1365-2125.1992.tb04005.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Regulation of body temperature in health and disease.

Authors:  G PICKERING
Journal:  Lancet       Date:  1958-01-04       Impact factor: 79.321

2.  Characterization of opioid receptors involved in the modulation of NANC neurotransmission in the mammalian heart.

Authors:  A Rubino; L Mantelli; S Amerini; F Ledda
Journal:  Acta Physiol Hung       Date:  1990

3.  Effects of opioid antagonism on the haemodynamic and hormonal responses to exercise.

Authors:  J Staessen; R Fiocchi; R Bouillon; R Fagard; P Hespel; P Lijnen; E Moerman; A Amery
Journal:  Clin Sci (Lond)       Date:  1988-09       Impact factor: 6.124

4.  The responses of the catecholamines and beta-endorphin to brief maximal exercise in man.

Authors:  S Brooks; J Burrin; M E Cheetham; G M Hall; T Yeo; C Williams
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

5.  A radioimmunoassay for rat plasma ACTH.

Authors:  L H Rees; D M Cook; J W Kendall; C F Allen; R M Kramer; J G Ratcliffe; R A Knight
Journal:  Endocrinology       Date:  1971-07       Impact factor: 4.736

Review 6.  Classification of opioid receptors.

Authors:  S J Paterson; L E Robson; H W Kosterlitz
Journal:  Br Med Bull       Date:  1983-01       Impact factor: 4.291

7.  Altered pituitary hormone response to naloxone in hypertension development.

Authors:  J A McCubbin; R S Surwit; R B Williams; C B Nemeroff; M McNeilly
Journal:  Hypertension       Date:  1989-12       Impact factor: 10.190

8.  Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia.

Authors:  G L Jennings; A Bobik; E T Fagan; P I Korner
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

9.  Modulation by Leu-enkephalin of peptide release from perifused neurointermediate pituitary. II. Inhibition of calcium-mediated secretion of alpha-MSH and beta-endorphin.

Authors:  M Al Zein; B Lutz-Bucher; B Koch
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

10.  Characterization of opioid receptors modulating the function of capsaicin-sensitive neurons in guinea-pig atria.

Authors:  L Mantelli; S Amerini; A Rubino; F Ledda
Journal:  Eur J Pharmacol       Date:  1990-05-16       Impact factor: 4.432

View more
  1 in total

1.  Advocating neuroimaging studies of transmitter release in human physical exercise challenges studies.

Authors:  Henning Boecker; Ahmed Othman; Sarah Mueckter; Lukas Scheef; Max Pensel; Marcel Daamen; Jakob Jankowski; Hh Schild; Tr Tölle; M Schreckenberger
Journal:  Open Access J Sports Med       Date:  2010-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.